Home >> Tag Archives: XRGenomics—

Tag Archives: XRGenomics—

Affymetrix, XRGenomics join forces

Nov. 25, 2015—Affymetrix and XRGenomics, UK-based biotechnology company, announced that they will collaborate on research and development of a new generation of diagnostic tests for age-related diseases. XRGenomics has used Affymetrix technology to develop novel gene expression-based signatures that enable translational research and biomarker test development activities in areas such as dementia, Alzheimer disease, and other age-related diseases. XRGenomics officials hope ...

Read More »